First Time Loading...
S

Shanghai MicroPort MedBot Group Co Ltd
HKEX:2252

Watchlist Manager
Shanghai MicroPort MedBot Group Co Ltd
HKEX:2252
Watchlist
Price: 15.86 HKD 5.45% Market Closed
Updated: May 9, 2024
Section:
 

Wall Street
Price Targets

Price Targets Summary
Shanghai MicroPort MedBot Group Co Ltd

Wall Street analysts forecast Shanghai MicroPort MedBot Group Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Shanghai MicroPort MedBot Group Co Ltd is 29.86 HKD with a low forecast of 15.25 HKD and a high forecast of 49.35 HKD.

Lowest Forecast
Wall Street Target
15.25 HKD
4% Downside
Average Forecast
Wall Street Target
29.86 HKD
88% Upside
Highest Forecast
Wall Street Target
49.35 HKD
211% Upside
Lowest
Price Target
15.25 HKD
4% Downside
Average
Price Target
29.86 HKD
88% Upside
Highest
Price Target
49.35 HKD
211% Upside
Shanghai MicroPort MedBot Group Co Ltd Competitors:
Price Targets
SEZI
Senzime AB (publ)
96% Upside
I
041830
InBody Co Ltd
31% Upside
J
300529
Jafron Biomedical Co Ltd
7% Upside
R
REG1V
Revenio Group Oyj
7% Upside
SEZI
Senzime AB (publ)
96% Upside
I
041830
InBody Co Ltd
31% Upside
J
300529
Jafron Biomedical Co Ltd
7% Upside
R
REG1V
Revenio Group Oyj
7% Upside
OPS
Opsens Inc
16% Upside
J
002223
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
25% Upside
HOLX
Hologic Inc
16% Upside
G
122310
Genoray Co Ltd
497% Upside

Revenue
Forecast

Revenue Estimate
Shanghai MicroPort MedBot Group Co Ltd

The compound annual growth rate of Shanghai MicroPort MedBot Group Co Ltd's revenue for the next 3 years is 137%.

N/A
Past Growth
137%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Shanghai MicroPort MedBot Group Co Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Shanghai MicroPort MedBot Group Co Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
6%
Average Beat
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Shanghai MicroPort MedBot Group Co Ltd's stock price target?
Price Target
29.86 HKD

According to Wall Street analysts, the average 1-year price target for Shanghai MicroPort MedBot Group Co Ltd is 29.86 HKD with a low forecast of 15.25 HKD and a high forecast of 49.35 HKD.

What is Shanghai MicroPort MedBot Group Co Ltd's Revenue forecast?
Projected CAGR
137%

The compound annual growth rate of Shanghai MicroPort MedBot Group Co Ltd's revenue for the next 3 years is 137%.

ALPHA SPREAD
Join more than 135,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.